Veracyte, Inc. (VCYT): Price and Financial Metrics
Veracyte, Inc. (VCYT)
Today's Latest Price: $27.71 USD
0.98 (3.67%)
Updated Jul 2 4:00pm
Add VCYT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
VCYT Stock Summary
- With a price/sales ratio of 10.63, Veracyte Inc has a higher such ratio than 88.14% of stocks in our set.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.14 for Veracyte Inc; that's greater than it is for merely 10.31% of US stocks.
- With a year-over-year growth in debt of -50.47%, Veracyte Inc's debt growth rate surpasses just 5.08% of about US stocks.
- Stocks that are quantitatively similar to VCYT, based on their financial statements, market capitalization, and price volatility, are IRTC, NVRO, ATRC, SIBN, and INSP.
- VCYT's SEC filings can be seen here. And to visit Veracyte Inc's official web site, go to www.veracyte.com.
VCYT Daily Price Range
VCYT 52-Week Price Range
VCYT Stock Price Chart Technical Analysis Charts
VCYT Price/Volume Stats
| Current price | $27.71 | 52-week high | $31.18 |
| Prev. close | $26.73 | 52-week low | $13.90 |
| Day low | $27.00 | Volume | 616,327 |
| Day high | $28.15 | Avg. volume | 488,097 |
| 50-day MA | $25.81 | Dividend yield | N/A |
| 200-day MA | $25.33 | Market Cap | 1.39B |
Veracyte, Inc. (VCYT) Company Bio
Veracyte Inc. operates as a molecular diagnostics company in the United States. It operates in the field of molecular cytology with genomic solutions that resolve diagnostic ambiguity and enable physicians to make informed treatment decisions at an early stage in patient care. The company was founded in 2006 and is based in San Francisco, California.
Loading social stream, please wait...